1. Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases.
- Author
-
de La Motte Rouge T, Pautier P, Rey A, Duvillard P, Kerbrat P, Troalen F, Morice P, Haie-Meder C, Culine S, and Lhommé C
- Subjects
- Endodermal Sinus Tumor drug therapy, Endodermal Sinus Tumor surgery, Female, France epidemiology, Humans, Infertility, Female prevention & control, Kaplan-Meier Estimate, Neoplasm Recurrence, Local mortality, Ovarian Neoplasms drug therapy, Ovarian Neoplasms surgery, Prognosis, Retrospective Studies, Young Adult, alpha-Fetoproteins metabolism, Endodermal Sinus Tumor mortality, Ovarian Neoplasms mortality
- Abstract
Background: Ovarian yolk sac tumour (OYST) is a very rare malignancy arising in young women. Our study aimed to evaluate long-term outcomes and to identify prognostic parameters likely to help make appropriate risk-based decisions about therapy in this disease., Methods: This retrospective study is based on prospectively recorded OYST cases at the Institut Gustave-Roussy. A univariate analysis using the logrank test evaluated possible associations between survival and patient or disease covariates. The multivariate analysis was performed using the Cox proportional hazard regression method., Results: Between 1976 and 2006, 84 patients were registered. Since 1991, most of the patients have undergone fertility-sparing surgery. With a median follow-up of 71 months, the overall 5-year and event-free survival rates are 84% and 79%, respectively. In the multivariate model only the absence of ascites and a favourable serum AFP decline rate were significantly associated with better overall survival., Conclusions: Patients with a poor prognosis factor such as an unfavourable serum AFP decline may be considered for aggressive treatment whereas those with good prognostic factors could be given less courses of chemotherapy., (Copyright © 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF